Milestone Scientific (MLSS) - צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים

Milestone Scientific (MLSS) is optimizing expenses by outsourcing electronics production to third-party contractors. Tracking quarterly EPS growth confirms the asset's stability, with the value holding at 37.10. The business foundation is built upon painless injection patents and strict FDA oversight. Partnerships with medical centers to implement the CompuFlo system are expanding the company's presence in dentistry and anesthesiology.

For Milestone Scientific (MLSS), whose dominance in the anesthesia systems niche is secured by patent protection and physician conservatism, the quarterly EPS growth rate serves as an indicator of the monetization of these market barriers. This metric measures the quarterly net profit per share dynamics, comparing financial results with market value, which allows for an assessment of real capital efficiency and the risk of overpaying for the asset.